PHAR-2212 - USA (Virginia) - Pharmacy Benefits Manager Service - Deadline September 16,2026

(1) Vendor needs to provide pharmacy benefits manager service to the government authority located in Virginia. – Provide pharmacy benefit management services supporting active employees and pre–65 retirees. Offerors should describe how the PBM will coordinate with the selected medical TPA, including accumulator integration, eligibility exchange, claims data, and reporting.• Administer the Employer's prescription drug benefit in accordance with plan documents and applicable laws and regulations.• Provide dedicated account management and implementation resources.• Coordinate services with the Employer, medical TPA, consultants, stop–loss carrier, and other benefit vendors.• Maintain all required licenses, certifications, and accreditations.• Provide strategic pharmacy consulting and market intelligence.• Participate in regular stewardship and performance review meetings.• Review formulary changes on a regular basis.• Implement formulary management strategies designed to balance clinical efficacy and cost–effectiveness.• Provide advance notice of formulary changes.• Support custom formulary options upon request.• Monitor network adequacy and access standards.• Negotiate competitive pharmacy reimbursement rates.• Provide network disruption analysis.• Support member pharmacy choice.• Home delivery options• Maintenance medication management• Automatic refill programs, where permitted• Medication adherence programs• Clinical pharmacist support• Clinical care management• Prior authorization review• Adherence monitoring• Patient education and support• Site–of–care optimization strategies• Prior authorization programs• Step therapy programs• Quantity limits• Drug utilization review (DUR)• Opioid management programs• Biosimilar management strategies• Specialty medication management• Toll–free member service support• Clinical pharmacist consultation• Secure member portal access• Mobile application access(2) All the questions must be submitted no later than September 11, 2026.